WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 7'2201 Infant (under 12 months) mortality rate: 12
GDP / capita (US$): 17'5121 Child (under 5 years) mortality rate: 12

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 7'150  7'201  7'253  7'304  7'355  8'001  8'821  8'865 
Births 68  68  69  70  71  65  105  133 
Surviving infants 67  68  69  70  71  64  103  130 
Pop. less than 5 years 337  344  354  363  366  330  557  677 
Pop. less than 15 years 1'011  1'007  1'006  1'007  1'006  1'254  1'792  1'961 
Female 15-49 years 1'570  1'593  1'616  1'638  1'660  1'936  2'104  2'140 

Number of reported cases

(Click for retrospective incidence data for Bulgaria)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  14  157  46  147  10'763 
Mumps
ChartChart
  18  31  25  58  139  2'357 
Pertussis
ChartChart
  35  52  89  102  46  106  26  154 
Polio*
ChartChart
  15 
Rubella
ChartChart
  10  18  41  28'449 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  18 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bulgaria)
Vaccine year result method % card seen                                                
BCG          96  97  97  97  98  98 
DTP1          93  90  96  96  96  95 
DTP3          91  88  95  95  95  93 
DTP4          65  78 
IPV1          93  90 
HepB_BD          97  98  98  98  99  98 
HepB3          92  95  95  95  96  94 
Hib3          87  83  95  95  95  90 
JapEnc         
MCV1          92  93  95  94  94  89 
MCV2          87  89  94  94  94  83 
PCV1          95  95  96  95  96 
PCV3          90  92  94  94  94 
Pol3          91  88  95  95  95  94 
Rota1         
RotaC         
RCV1          92  93  95  94  94 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bulgaria)
BCG
ChartChart
  96  97  97  97  98  98  99  99 
DTP1
ChartChart
  93  90  96  96  96  95  99  98 
DTP3
ChartChart
  91  88  95  95  95  93  99  98 
HepB3
ChartChart
  92  95  95  95  96  94 
HepB_BD
ChartChart
  97  98  98  98  99  98 
Hib3
ChartChart
  87  83  95  95  95 
MCV1
ChartChart
  92  93  95  94  95  89  99  98 
MCV2
ChartChart
  87  89  94  94  94  83 
PCV3
ChartChart
  90  92  94  94  94 
Pol3
ChartChart
  91  88  95  95  95  94  99  99 
RCV1
ChartChart
  92  93  95  94  95  89 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 36
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; 7 months; 7, 11, 17 years; Yes after Manntoux test negative
DTaPHibHepIPV 2, 3, 4 months; Yes
DTaPHibIPV 2, 3, 4, 16 months; Yes
DTaPIPV 6 years; Yes
HepB Birth; 1, 6 months; Yes
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, health care workers, and other risk groups
Influenza_Pediatric Yes children with chronic diseases
MMR 13 months; 12 years; Yes
Pneumo_conj 2, 3, 4, 12 months; Yes
Rabies Yes As post-exposure prophylaxis
Td 12, 17, 25, 35, 45, 55 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  Yes  No 
What years does the MYP cover? number           2005-2010  2005-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 28  28  28  28  28  28  28 

System performance

Total Nº districts in country number 28  28  28  28  28  28  28 
Nº districts with DTP3 coverage >=80% number 26  23  28  28  28  27  27 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  82  100  100  100  96  96 
Nº districts with measles (MCV1) coverage >=95% number 14  16  13  13  19  28 
% of districts with MCV1 coverage >=95% From 0 to 100% 32  50  57  46  46  68  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       100  100  100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  NA  No   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.